Mahoney brings deep market expertise to guide biotech and pharmaceutical occupiers BOSTON, MA / ACCESS Newswire / ...

Genentech was acquired by pharmaceutical giant Roche in 2009 for $46.8B. The company has been expanding elsewhere, including North Carolina, where it plans to double its investment to $2B, Reuters ...

Dr. Margulis has more than 25 years of science and business development experience in the Life Science industry and is currently a Chief Operating Officer at Mansfield Bio-Incubator, building an ...

Boston's life sciences cluster was built on the promise that if you earned a doctorate and came to Kendall Square, the jobs ...

After holding its breath for several rough years, Greater Boston’s life sciences sector is cautiously coming up for air.

From lab space and coffee bars to jobs and long-term returns, mid-tier life sciences hubs may be better positioned than the biggest biotech boomtowns.

More than 500 young life sciences entrepreneurs arrived on one of the Boston Harbor islands this week. While they were there for the annual Nucleate Alumni Summit, the vibe was a cross between a ...

Lydian, a Massachusetts-based provider of synthetic fuels, has opened a 25,000-square-foot life sciences facility in Charlestown, located north of Boston. The space is located within Hood Park, a ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. As scientific and technological developments continue to ...

A consortium of Boylston Properties and its affiliates has secured $119.15 million to refinance 500 Forge, a recently redeveloped Class A life sciences property that spans nearly 160,000 square-feet ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Life science is an exacting industry. Labs, manufacturing ...

It’s an abrupt change of course for the long-vacant parcel known as P3, where developers have struggled for decades to get ...